Spots Global Cancer Trial Database for atg
Every month we try and update this database with for atg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT01471444 | Disorder Relate... Leukemia Transplantation... | Fludarabine Clofarabine Busulfan Thymoglobulin Stem Cell Infus... Tacrolimus Methotrexate | 3 Years - 70 Years | M.D. Anderson Cancer Center | |
| Stem Cell Transplantation for Hematological Malignancies | NCT00176839 | Leukemia, Lymph... AML MDS | Stem Cell Trans... Busulfan Cyclophosphamid... Melphalan G-CSF ATG | - 35 Years | Masonic Cancer Center, University of Minnesota | |
| Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients | NCT00499889 | Leukemia | Imatinib Mesyla... Fludarabine (Fl... Busulfan Antithymocyte G... Tacrolimus Methotrexate Donor lymphocyt... Stem Cell Trans... | - 70 Years | M.D. Anderson Cancer Center | |
| Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome | NCT00475020 | Myelofibrosis | Busulfan Fludarabine Thymoglobulin (... | - 75 Years | M.D. Anderson Cancer Center | |
| Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation | NCT05634915 | Hematopoietic S... Acute Leukemia | Individual ATG ATG | 16 Years - 60 Years | The First Affiliated Hospital of Soochow University | |
| Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT01471444 | Disorder Relate... Leukemia Transplantation... | Fludarabine Clofarabine Busulfan Thymoglobulin Stem Cell Infus... Tacrolimus Methotrexate | 3 Years - 70 Years | M.D. Anderson Cancer Center | |
| Stem Cell Transplantation for Hematological Malignancies | NCT00176839 | Leukemia, Lymph... AML MDS | Stem Cell Trans... Busulfan Cyclophosphamid... Melphalan G-CSF ATG | - 35 Years | Masonic Cancer Center, University of Minnesota | |
| Stem Cell Transplantation for Hematological Malignancies | NCT00176839 | Leukemia, Lymph... AML MDS | Stem Cell Trans... Busulfan Cyclophosphamid... Melphalan G-CSF ATG | - 35 Years | Masonic Cancer Center, University of Minnesota | |
| Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin | NCT00822770 | Stem Cell Trans... Leukemia | Plerixafor Filgrastim Fludarabine Busulfan Allogeneic bloo... ATG (Thymoglobu... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin | NCT00822770 | Stem Cell Trans... Leukemia | Plerixafor Filgrastim Fludarabine Busulfan Allogeneic bloo... ATG (Thymoglobu... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies | NCT00857389 | Stem Cell Trans... Leukemia Lymphoma | Thiotepa Clofarabine Busulfan Allogeneic Stem... Thymoglobulin (... G-CSF (Filgrast... Tacrolimus Methotrexate Cyclophosphamid... Mesna | - 60 Years | M.D. Anderson Cancer Center | |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies | NCT01471067 | Blood And Marro... Leukemia Lymphoma Transplantation... Transplantation... | Melphalan Fludarabine Mycophenolate m... Tacrolimus Cord Blood Infu... Rituximab ATG Busulfan Clofarabine Total Body Irra... | 1 Year - 80 Years | M.D. Anderson Cancer Center | |
| Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT | NCT05917405 | Acute Myeloid L... | Fludarabine Busulfan ATG Clofarabine | 18 Years - 99 Years | Nantes University Hospital | |
| ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors | NCT02938741 | Lymphoblastic L... | Anti-human Thym... Placebo | 18 Years - 60 Years | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | |
| Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT | NCT03395860 | Graft-versus-ho... Prophylaxis | ATG | 14 Years - 70 Years | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | |
| Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT00402558 | Myelodysplastic... Leukemia | Thymoglobulin Busulfan Fludarabine Alloreactive NK... G-CSF Tacrolimus Methotrexate Interleukin-2 | - 70 Years | M.D. Anderson Cancer Center | |
| PTCy and ATG for MSD and MUD Transplants | NCT06299462 | Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Hodgkin Lymphom... Non-hodgkin Lym... | ATG 5.0 Cyclophosphamid... ATG 2.5±1.5 | 18 Years - 60 Years | Instituto Nacional de Cancer, Brazil | |
| Allogeneic Stem Cell Transplantation for Children With CML | NCT02707393 | Chronic Myeloid... | Fludarabine Thiotepa Melphalan ATG Cyclosporine A Mycophenolate m... bone marrow or ... | 1 Year - 18 Years | St. Anna Kinderkrebsforschung | |
| M-PTCy vs BuCy in Haploidentical HSCT for Acute Leukemia | NCT05739630 | Acute Leukemia | mitoxantrone li... ATG | 14 Years - 60 Years | The First Affiliated Hospital of Soochow University | |
| Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas | NCT01786018 | B-cell Lymphoma... | Thiotepa Busulfan Fludarabin transplant (HCT... Cytoreduction Immunosuppressi... Cyclosporine Methotrexate ATG Collection and ... | 18 Years - 65 Years | Azienda Ospedaliera San Giovanni Battista | |
| Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML) | NCT01063660 | Acute Myeloid L... | Treosulfan | 18 Years - 60 Years | medac GmbH | |
| Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT00402558 | Myelodysplastic... Leukemia | Thymoglobulin Busulfan Fludarabine Alloreactive NK... G-CSF Tacrolimus Methotrexate Interleukin-2 | - 70 Years | M.D. Anderson Cancer Center | |
| Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor | NCT00523809 | Breast Cancer Ovarian Cancer | Bevacizumab Allogeneic Hema... Fludarabine Melphalan Thymoglobulin | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies | NCT00521859 | Hematologic Mal... | Cloretazine Fludarabine | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS | NCT00038831 | Acute Myelogeno... Myelodysplastic... Chronic Lymphoc... | Mylotarg Fludarabine Melphalan Anti-thymocyte ... Stem cell trans... | 12 Years - 75 Years | M.D. Anderson Cancer Center | |
| A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT | NCT03190733 | Chronic Graft-v... Leukemia Relaps... | ATG | 14 Years - 60 Years | Zhujiang Hospital | |
| ATG Plus Low-dose PT-Cy for GVHD Prevention | NCT06108739 | Hematologic Mal... | Cyclophosphamid ATG | 12 Years - 55 Years | Peking University People's Hospital | |
| Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia | NCT00005937 | Myelodysplastic... | Antithymocyte g... Cyclosporine | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells | NCT01362452 | Leukemia Lymphoma | T-Cell Infusion Cord Blood Infu... | 1 Year - 75 Years | M.D. Anderson Cancer Center | |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies | NCT01471067 | Blood And Marro... Leukemia Lymphoma Transplantation... Transplantation... | Melphalan Fludarabine Mycophenolate m... Tacrolimus Cord Blood Infu... Rituximab ATG Busulfan Clofarabine Total Body Irra... | 1 Year - 80 Years | M.D. Anderson Cancer Center | |
| Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies | NCT00521859 | Hematologic Mal... | Cloretazine Fludarabine | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT | NCT03190733 | Chronic Graft-v... Leukemia Relaps... | ATG | 14 Years - 60 Years | Zhujiang Hospital | |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies | NCT00857389 | Stem Cell Trans... Leukemia Lymphoma | Thiotepa Clofarabine Busulfan Allogeneic Stem... Thymoglobulin (... G-CSF (Filgrast... Tacrolimus Methotrexate Cyclophosphamid... Mesna | - 60 Years | M.D. Anderson Cancer Center | |
| PTCy and ATG for MSD and MUD Transplants | NCT06299462 | Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Hodgkin Lymphom... Non-hodgkin Lym... | ATG 5.0 Cyclophosphamid... ATG 2.5±1.5 | 18 Years - 60 Years | Instituto Nacional de Cancer, Brazil | |
| Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease | NCT00385788 | Hodgkin's Disea... | Gemcitabine Fludarabine Melphalan Antithymocyte G... Allogeneic Stem... Tacrolimus Filgrastim (G-C... Methotrexate | - 65 Years | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
